✉news HealthMedicine first seen 2 d ago, last 1 d ago, peak #1
New guidance targets dangerous 'rhino tranq' withdrawal
Original: New guidance targets dangerous ‘rhino tranq’ withdrawal
New clinical guidance has been issued on treating withdrawal from xylazine, the animal sedative increasingly found mixed into illicit opioids and nicknamed the 'rhino tranq'. Unlike opioid withdrawal, xylazine withdrawal can be severe and difficult to manage with standard treatments, and the guidance aims to give clinicians a clearer approach as the drug spreads in the fentanyl supply.
Why now: Xylazine contamination of the illicit drug supply is growing, prompting health experts to publish treatment guidance for its dangerous withdrawal.
University of Cincinnatixylazinefentanyl
Rank over time, top of the chart is #1. 16 snapshots from 2 d ago to 1 d ago.
Evidence
- New guidance targets dangerous ‘rhino tranq’ withdrawal · University of Cincinnati
- New Guidance Targets Dangerous ‘Rhino Tranq’ Withdrawal · Medscape
API: https://socialmediatrends-api.osmike.com/v1/trends/6489032